Jointown Pharmaceutical Group Company Limited’s Net Profit Rose 25.1% in First Quarter of 2023

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 598.4 million yuan in the first quarter of 2023, up 25.1% year-on-year.

Meanwhile, the company posted 42.1 billion yuan in revenue, up 19.8% year-on-year.

At the end of the reporting period, it had 96.4 billion yuan in total assets and 67.2 billion yuan in total liabilities, with a liability-to-asset ratio of 69.7%.